-
1.发明授权Re-epithelializing pharmaceutical compositions containing xanthan gum 有权含有黄原胶Reepithelialisierende药物组合物
公开(公告)号：EP1913948B1
公开(公告)日：2011-10-12
申请号：EP07108593.0
申请日：2002-04-30
申请人： Sifi S.p.A.
IPC分类号： A61K31/715 , A61K9/00 , A61K47/36
CPC分类号： A61K31/723 , A61K9/0048 , A61K9/06 , A61K31/573 , A61K31/661 , A61K31/7036 , A61K31/715 , A61K31/728 , A61K47/36 , A61K2300/00
-
公开(公告)号：EP4171510B1
公开(公告)日：2024-10-16
申请号：EP21754827.0
申请日：2021-06-24
-
公开(公告)号：EP2129365B1
公开(公告)日：2022-03-02
申请号：EP07858130.3
申请日：2007-12-24
-
4.发明公开
公开(公告)号：EP3519590A1
公开(公告)日：2019-08-07
申请号：EP17791158.3
申请日：2017-09-29
申请人： SIFI S.p.A.
IPC分类号： C12Q1/68
摘要： The present invention relates to a method for estimating the risk factor (HR) for the onset of macular degeneration in a subject, which method comprises the evaluation of a first series of genetic parameters comprising at least the genetic loci R1210C in CFH, variants in COL8A1 and RAD51 B, and the evaluation of a second series of environmental, individual and/or clinical parameters. This method is characterized in that said risk factor (HR) is calculated by assigning a greater importance to said evaluation of the first series of genetic parameters with respect to said evaluation of the second series of environmental, individual and/or clinical parameters. The method of the present invention thus allows to estimate the genetic risk of AMD more accurately than the methods known in the art.
-
公开(公告)号：EP4069196B1
公开(公告)日：2024-01-31
申请号：EP20853537.7
申请日：2020-12-04
-
公开(公告)号：EP3634456B1
公开(公告)日：2023-11-22
申请号：EP17748916.8
申请日：2017-06-19
发明人： SANTOCONO, Marcello , SANTONOCITO, Manuela , ZAPPULLA, Cristina , LA ROSA, Luca Rosario , GIULIANO, Francesco , MAZZONE, Maria Grazia
IPC分类号： A61K36/88 , A61K36/9066 , A61K38/48 , A61K45/06 , A61K31/05 , A61K31/07 , A61K31/122 , A61K31/125 , A61K31/4525 , A61K36/02 , A61K36/28 , A61K36/324 , A61K36/67 , A61K36/704 , A61P9/10 , A61P27/02
-
7.发明公开Re-epithelializing pharmaceutical compositions containing xanthan gum 有权复制上皮炎药物Zusammensetzungen，死亡Xanthangummi焓
公开(公告)号：EP1913948A1
公开(公告)日：2008-04-23
申请号：EP07108593.0
申请日：2002-04-30
申请人： Sifi S.p.A.
IPC分类号： A61K31/715 , A61K9/00 , A61K47/36
CPC分类号： A61K31/723 , A61K9/0048 , A61K9/06 , A61K31/573 , A61K31/661 , A61K31/7036 , A61K31/715 , A61K31/728 , A61K47/36 , A61K2300/00
摘要： The present invention relates to the use of xanthan gum as re-epithelializing agent and, in particular, to a pharmaceutical formulation comprising xanthan gum as a re-epithelializing active principle. Said use and composition speed up and improve advantageously the formation of newly grown epithelium.
摘要翻译： 本发明涉及黄原胶作为再上皮化剂的用途，特别涉及包含黄原胶作为再上皮化活性成分的药物制剂。 所述使用和组合物加速并有利地改善新生的上皮的形成。
-
8.发明授权Re-epithelializing pharmaceutical compositions containing xanthan gum 有权黄原胶含有医药制剂reepithelialisierende
公开(公告)号：EP1358883B8
公开(公告)日：2007-10-03
申请号：EP02425274.4
申请日：2002-04-30
申请人： Sifi S.p.A.
发明人： Mazzone, Maria Grazia, c/o Sifi S.p.A. , Paladino, Grazia, c/o Sifi S.p.A. , Marino, Clara, c/o Sifi S.p.A. , Peri, Ornella, c/o Sifi S.p.A. , Enea, Vincenzo, c/o Sifi S.p.A.
IPC分类号： A61K31/715 , A61K9/00 , A61K47/36 , A61P27/02
CPC分类号： A61K31/723 , A61K9/0048 , A61K9/06 , A61K31/573 , A61K31/661 , A61K31/7036 , A61K31/715 , A61K31/728 , A61K47/36 , A61K2300/00
-
公开(公告)号：EP4216966B1
公开(公告)日：2024-11-13
申请号：EP21815670.1
申请日：2021-11-11
-
-
-
-
-
-
-
-
-
搜索结果
22 条记录 (耗时 0.01 秒)
